Inventor
CHEN BINGLIANG
US19 patents
⚠️ This page may combine multiple inventors who share the name “CHEN BINGLIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SQUIBB & SONS LLC
5 patentsUS9492540B2Nov 15, 2016
Methods for treating cancer using anti-PD-1 antibodies
SQUIBB & SONS LLC139 citations99
US9492539B2Nov 15, 2016
Monoclonal antibodies to Programmed Death 1 (PD-1)
SQUIBB & SONS LLC119 citations99
US9387247B2Jul 12, 2016
Monoclonal antibodies to programmed death 1 (PD-1)
SQUIBB & SONS LLC124 citations99
US9358289B2Jun 7, 2016
Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies
SQUIBB & SONS LLC137 citations99
US10441655B2Oct 15, 2019
Monoclonal antibodies to programmed death 1 (PD-1)
SQUIBB & SONS LLC25 citations94
INNOVENT BIOLOGICS SUZHOU CO LTD
4 patentsUS11292836B2Apr 5, 2022
Anti-CD47 antibodies and uses thereof
INNOVENT BIOLOGICS SUZHOU CO LTD3 citations71
US11512131B2Nov 29, 2022
Anti-PD-L1 antibody and uses thereof
INNOVENT BIOLOGICS SUZHOU CO LTD1 citations59
US11655296B2May 23, 2023
Anti-CD47 antibody and use thereof
INNOVENT BIOLOGICS SUZHOU CO LTD0 citations51
US11498972B2Nov 15, 2022
Anti-OX40 antibody and use thereof
INNOVENT BIOLOGICS SUZHOU CO LTD0 citations51
TERRETT JONATHAN A
3 patentsUS8268970B2Sep 18, 2012
Human antibodies that bind mesothelin, and uses thereof
TERRETT JONATHAN A65 citations96
US8399623B2Mar 19, 2013
Human antibodies that bind mesothelin, and uses thereof
TERRETT JONATHAN A25 citations91
US8425904B2Apr 23, 2013
Human antibodies that bind mesothelin, and uses thereof
TERRETT JONATHAN A9 citations82